Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions
Background: Coronavirus disease 2019 (COVID-19) is associated with a wide variety of clinical manifestations. Aim: This study aims to evaluate the levels of angiotensin-converting enzyme 2 (ACE2), metalloprotease 17 (ADAM17), Interleukin-17A (IL-17A), transmembrane serine protease 2 (TMPRSS2), apeli...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/15/2/324 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850081756982542336 |
|---|---|
| author | Mina Pencheva Neshka Manchorova-Veleva David Baruh Georgi Rusinov Lyubomir Vangelov |
| author_facet | Mina Pencheva Neshka Manchorova-Veleva David Baruh Georgi Rusinov Lyubomir Vangelov |
| author_sort | Mina Pencheva |
| collection | DOAJ |
| description | Background: Coronavirus disease 2019 (COVID-19) is associated with a wide variety of clinical manifestations. Aim: This study aims to evaluate the levels of angiotensin-converting enzyme 2 (ACE2), metalloprotease 17 (ADAM17), Interleukin-17A (IL-17A), transmembrane serine protease 2 (TMPRSS2), apelin (AP), and vitamin D (VD) biomarkers in nasopharyngeal swab (NPS), serum, and saliva, as well as the change in their values depending on the health status of individuals. Material and methods: The analysis was performed by using enzyme-linked immunosorbent assay (ELISA) methods. Results: Comparing the levels of the investigated markers in saliva, we found significantly elevated ACE2 values in vaccinated patients, followed by those with severe COVID-19, compared to healthy, previously infected, and mild COVID-19 groups. For TMPRSS2, IL-17A, ADAM-17, and AP, values were significantly higher in all non-healthy groups (previously infected, mild, and severe COVID-19) compared to healthy individuals. Serum levels of VD were consistently low across all five studied groups, suggesting values below normal ranges. Analysis of marker data in saliva, NPS, and serum revealed a positive correlation between NPS and serum and saliva and serum, as well as between saliva and NPS for all studied markers. Conclusions: In summary, monitoring changes in biomarkers present in Saliva holds promise as a predictive tool for various diseases. This approach enables the early implementation of preventive measures and protective strategies, potentially improving overall health outcomes. |
| format | Article |
| id | doaj-art-a1e2bdc4738e445a86a651564457be63 |
| institution | DOAJ |
| issn | 2075-1729 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj-art-a1e2bdc4738e445a86a651564457be632025-08-20T02:44:39ZengMDPI AGLife2075-17292025-02-0115232410.3390/life15020324Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health ConditionsMina Pencheva0Neshka Manchorova-Veleva1David Baruh2Georgi Rusinov3Lyubomir Vangelov4Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, BulgariaDepartment of Operative Dentistry and Endodontics, Faculty of Dental Medicine, Medical University of Plovdiv, 4002 Plovdiv, BulgariaDepartment of Software Engineering, Faculty of Mathematics and Informatics, Sofia University “St. Kliment Ohridski”, 1164 Sofia, BulgariaClinic of Infectious Diseases, University Hospital St. George JSC in Plovdiv, 4021 Plovdiv, BulgariaDepartment of Operative Dentistry and Endodontics, Faculty of Dental Medicine, Medical University of Plovdiv, 4002 Plovdiv, BulgariaBackground: Coronavirus disease 2019 (COVID-19) is associated with a wide variety of clinical manifestations. Aim: This study aims to evaluate the levels of angiotensin-converting enzyme 2 (ACE2), metalloprotease 17 (ADAM17), Interleukin-17A (IL-17A), transmembrane serine protease 2 (TMPRSS2), apelin (AP), and vitamin D (VD) biomarkers in nasopharyngeal swab (NPS), serum, and saliva, as well as the change in their values depending on the health status of individuals. Material and methods: The analysis was performed by using enzyme-linked immunosorbent assay (ELISA) methods. Results: Comparing the levels of the investigated markers in saliva, we found significantly elevated ACE2 values in vaccinated patients, followed by those with severe COVID-19, compared to healthy, previously infected, and mild COVID-19 groups. For TMPRSS2, IL-17A, ADAM-17, and AP, values were significantly higher in all non-healthy groups (previously infected, mild, and severe COVID-19) compared to healthy individuals. Serum levels of VD were consistently low across all five studied groups, suggesting values below normal ranges. Analysis of marker data in saliva, NPS, and serum revealed a positive correlation between NPS and serum and saliva and serum, as well as between saliva and NPS for all studied markers. Conclusions: In summary, monitoring changes in biomarkers present in Saliva holds promise as a predictive tool for various diseases. This approach enables the early implementation of preventive measures and protective strategies, potentially improving overall health outcomes.https://www.mdpi.com/2075-1729/15/2/324ACE2biomarkersbody fluidCOVID-19infectious diseases |
| spellingShingle | Mina Pencheva Neshka Manchorova-Veleva David Baruh Georgi Rusinov Lyubomir Vangelov Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions Life ACE2 biomarkers body fluid COVID-19 infectious diseases |
| title | Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions |
| title_full | Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions |
| title_fullStr | Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions |
| title_full_unstemmed | Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions |
| title_short | Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions |
| title_sort | analysis of biomarker levels in nasopharyngeal swabs serum and saliva across different health conditions |
| topic | ACE2 biomarkers body fluid COVID-19 infectious diseases |
| url | https://www.mdpi.com/2075-1729/15/2/324 |
| work_keys_str_mv | AT minapencheva analysisofbiomarkerlevelsinnasopharyngealswabsserumandsalivaacrossdifferenthealthconditions AT neshkamanchorovaveleva analysisofbiomarkerlevelsinnasopharyngealswabsserumandsalivaacrossdifferenthealthconditions AT davidbaruh analysisofbiomarkerlevelsinnasopharyngealswabsserumandsalivaacrossdifferenthealthconditions AT georgirusinov analysisofbiomarkerlevelsinnasopharyngealswabsserumandsalivaacrossdifferenthealthconditions AT lyubomirvangelov analysisofbiomarkerlevelsinnasopharyngealswabsserumandsalivaacrossdifferenthealthconditions |